ENO2 and neoplasm: The ANN model combined with six tumor biomarkers, including CEA, gastrin, NSE, sialic acid (SA), Cu/Zn, and Ca, was used to successfully differentiate lung cancer from benign lung disease, a normal control, and gastrointestinal cancers[19].